证券记录 · 已归档季度
OLMA
Olema Pharmaceuticals, Inc. · Healthcare · Biotechnology
11被追踪持有人
—Δ持有人
6.52M持有股份
$70.59M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | -5 | 48.00M | $600.59M | +5 | −10 |
| Q1 2026 | 85 | +7 | 50.63M | $755.34M | +15 | −8 |
| Q4 2025 | 78 | +3 | 39.80M | $995.19M | +3 | — |
| Q3 2025 | 16 | 0 | 15.07M | $147.57M | +1 | −1 |
| Q2 2025 | 13 | -1 | 13.76M | $58.63M | — | −1 |
| Q1 2025 | 11 | -1 | 8.23M | $30.93M | +1 | −2 |
| Q4 2024 | 12 | 0 | 11.47M | $66.81M | — | — |
| Q3 2024 | 11 | 0 | 7.78M | $92.93M | +1 | −1 |
| Q2 2024 | 11 | — | 6.52M | $70.59M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 3.21M | — | $34.75M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 1.06M | — | $11.47M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 1.06M | — | $11.47M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 905.26K | — | $9.79M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 905.26K | — | $9.79M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 905.26K | — | $9.79M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 905.26K | — | $9.79M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 905.26K | — | $9.79M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 905.26K | — | $9.79M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Marshall Wace ✦ | 589.00K | — | $6.37M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Marshall Wace ✦ | 589.00K | — | $6.37M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 325.00K | — | $3.52M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 182.12K | — | $1.97M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 132.25K | — | $1.43M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 132.25K | — | $1.43M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 53.20K | — | $575,624 | 0.0% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 31.24K | — | $339,000 | 0.0% | n/c | 1 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 21.06K | — | $227,858 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 12.12K | — | $131,192 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 12.12K | — | $131,192 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 200.00K 股份, $10,000 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据